Health is a global concern and all stakeholders in society--including the pharmaceutical industry--have an ethical responsibility to contribute to promote health. At Novo Nordisk, we have decided to focus on defeating diabetes since this is the area where the company can make the biggest difference. Financial viability goes hand in hand with environmental and social responsibility, not only in ...

Recent years have seen an "explosion" in the abilities of scientists to use neuroscience in new domains. Unfortunately, it is little known and reported on how advertising companies make more effective pharmaceutical drugs commercials. The purpose of this paper is to analyze how neuromarketing techniques may impact the consumer response to pharmaceutical advertising campaigns. The result shows t...

BACKGROUND Press releases are a popular vehicle to disseminate health information to the lay media. While the quality of press releases issued by scientific conferences and medical journals has been questioned, no efforts to assess pharmaceutical industry press releases have been made. Therefore, we sought to systematically examine pharmaceutical company press releases about original research f...

Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands Dept. Infectious Diseases and Immunology, Div. Immunology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands Members of UNYPHAR, a network collaboration between the universities of Groningen, Leiden, Utrecht and the pharmaceutical company Yamanouchi CHAPTER THERAPEUTIC INDEX...

This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.

OBJECTIVE To examine the opinions of Libyan doctors regarding the quality of drug information provided by pharmaceutical company representatives (PCRs) during detailing visits. METHOD An anonymous survey was conducted among 1,000 doctors from selected institutes in Tripoli, Benghazi and Sebha. Doctors were asked questions regarding the quality of information provided during drug-detailing vis...

In 1987, a group infection of hepatitis in patients receiving a contaminated fibrinogen product was first reported to the Japanese regulatory agency. Eventually, this serious drug incident involved more than 10,000 cases of infection. In response, the Government of Japan established a responding inspection committee in 2008 to make recommendations for the restructuring of drug regulatory admini...

Collusion between insurers and drug companies Insurance companies and drug manufacturers can give consumers a headache when they join together. They may also be violating the law. The recently-proposed federal health care plans spark fear and apprehension in most areas of the health care industry. Many physicians, hospitals, and corporations are scrambling to predict the path of legislation and...